arbiter
JournalsAccount

The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals

Margaret Kyle

Innovation Policy and the Economy2019https://doi.org/10.1086/705640article
ABDC B
Weight
0.58

Abstract

This chapter provides an overview of different innovation policies and their performance in the pharmaceutical sector. I emphasize three points. First, both push and pull policies have generally promoted pharmaceutical research for diseases with large burdens. Second, imperfections in product and capital markets undermine the efficiency of pull policies. Similarly, the allocation of public funds is not always optimal, which limits the efficacy of push policies. Finally, interactions with other domestic policies and with policies in other countries are often overlooked in both economic studies of pharmaceutical research and development as well as policy choices.

12 citations

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1086/705640

Or copy a formatted citation

@article{margaret2019,
  title        = {{The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals}},
  author       = {Margaret Kyle},
  journal      = {Innovation Policy and the Economy},
  year         = {2019},
  doi          = {https://doi.org/https://doi.org/10.1086/705640},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.58

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.58 × 0.4 = 0.23
M · momentum0.80 × 0.15 = 0.12
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.